LU76879A1 - - Google Patents

Info

Publication number
LU76879A1
LU76879A1 LU76879A LU76879A LU76879A1 LU 76879 A1 LU76879 A1 LU 76879A1 LU 76879 A LU76879 A LU 76879A LU 76879 A LU76879 A LU 76879A LU 76879 A1 LU76879 A1 LU 76879A1
Authority
LU
Luxembourg
Application number
LU76879A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU76879A1 publication Critical patent/LU76879A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU76879A 1976-03-10 1977-03-02 LU76879A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9517/76A GB1541321A (en) 1976-03-10 1976-03-10 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
LU76879A1 true LU76879A1 (en:Method) 1977-07-12

Family

ID=9873507

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76879A LU76879A1 (en:Method) 1976-03-10 1977-03-02

Country Status (28)

Country Link
US (1) US4110460A (en:Method)
JP (1) JPS5927357B2 (en:Method)
AT (1) AT352716B (en:Method)
AU (1) AU503912B2 (en:Method)
BE (1) BE852259A (en:Method)
BG (1) BG28262A3 (en:Method)
CA (1) CA1074324A (en:Method)
CH (1) CH598267A5 (en:Method)
CS (1) CS190341B2 (en:Method)
DE (1) DE2709639A1 (en:Method)
DK (1) DK144702C (en:Method)
ES (1) ES456575A1 (en:Method)
FI (1) FI62313C (en:Method)
FR (1) FR2343748A1 (en:Method)
GB (1) GB1541321A (en:Method)
HU (1) HU172685B (en:Method)
IE (1) IE44280B1 (en:Method)
IL (1) IL51581A (en:Method)
LU (1) LU76879A1 (en:Method)
NL (1) NL7702446A (en:Method)
NO (1) NO150884C (en:Method)
PL (1) PL102603B1 (en:Method)
PT (1) PT66278B (en:Method)
RO (1) RO71301A (en:Method)
SE (1) SE431653B (en:Method)
SU (1) SU629882A3 (en:Method)
YU (1) YU61977A (en:Method)
ZA (1) ZA771303B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204067A (en) * 1976-09-24 1980-05-20 Adhikary Parimal K Derivatives of imidazo[2,1-b] thiazole
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
US4153706A (en) 1978-02-13 1979-05-08 Smithkline Corporation 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
FI800005A7 (fi) * 1979-01-05 1981-01-01 Ciba Geigy Ag Menetelmä uuden vasemmalle kiertävän bisyklisen tiadiatsayhdisteen ja sen suolojen valmistamiseksi.
US4364942A (en) * 1979-06-21 1982-12-21 Janssen Pharmaceutica N.V. 2,3-Dihydro-imidazo (2,1-b)benzothiazoles compositions useful as anti-parkinsonism agents
FR2463774A1 (fr) * 1979-08-21 1981-02-27 Yamanouchi Pharma Co Ltd Derives du 2-phenylimidazo(2,1-b)benzothiazole
FR2479831A1 (fr) * 1980-04-08 1981-10-09 Synthelabo Derives de thiazole, leur preparation et leur application en therapeutique
US4327221A (en) * 1980-10-15 1982-04-27 American Home Products Corporation 2-Substituted-3-hydroxythiazolo(2,3-8)-thiazolium salts and mesoionic didehydro derivatives thereof
US5134150A (en) * 1985-12-12 1992-07-28 Smithkline Beecham Corporation Inhibition of the 5-lipoxygenase pathway
US4751310A (en) * 1985-12-12 1988-06-14 Smithkline Beckman Corporation Inhibition of the 5-lipoxygenase pathway
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4719218A (en) * 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
ZW24186A1 (en) * 1985-12-12 1987-07-08 Smithkline Beckman Corp Inhibition of the 5-lipoxygenase pathway
US5145858A (en) * 1985-12-12 1992-09-08 Smithkline Beecham Corp. Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4794114A (en) * 1986-08-19 1988-12-27 Smithkline Beckman Corporation Inhibition of interleukin-1 production by monocytes and/or macrophages
US5630014A (en) * 1993-10-27 1997-05-13 Nec Corporation Gain controller with automatic adjustment using integration energy values
US6127387A (en) * 1996-12-10 2000-10-03 Thomas Jefferson University Use of CD4-binding small molecules to inhibit immune responses
WO2007034282A2 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (en:Method) * 1964-05-11
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles
NL164285C (nl) * 1968-01-09 1980-12-15 Rhone Poulenc Sa Werkwijze ter bereiding van een farmaceutisch preparaat, dat een imidazoÿ2.1-bÿthiazoolderivaat bevat, de gevormde farmaceutische preparaten, alsmede werkwijze voor het bereiden van dit imidazoÿ2.1-bÿthiazoolderivaat.

Also Published As

Publication number Publication date
NL7702446A (nl) 1977-09-13
PT66278A (fr) 1977-04-01
FI62313B (fi) 1982-08-31
NO150884B (no) 1984-09-24
JPS5927357B2 (ja) 1984-07-05
FI62313C (fi) 1982-12-10
US4110460A (en) 1978-08-29
ZA771303B (en) 1978-01-25
DK144702B (da) 1982-05-17
SE431653B (sv) 1984-02-20
BG28262A3 (bg) 1980-03-25
ATA164477A (de) 1979-03-15
ES456575A1 (es) 1978-02-16
RO71301A (ro) 1981-11-24
FI770759A7 (en:Method) 1977-09-11
YU61977A (en) 1982-06-30
IL51581A0 (en) 1977-05-31
CA1074324A (en) 1980-03-25
SE7702503L (sv) 1977-09-11
AU503912B2 (en) 1979-09-27
IE44280B1 (en) 1981-09-23
BE852259A (fr) 1977-09-09
IE44280L (en) 1977-09-10
CH598267A5 (en:Method) 1978-04-28
NO770841L (no) 1977-09-13
NO150884C (no) 1985-01-09
DK144702C (da) 1982-10-11
AU2315677A (en) 1978-09-14
DK104677A (da) 1977-09-11
DE2709639A1 (de) 1977-09-15
AT352716B (de) 1979-10-10
JPS52136195A (en) 1977-11-14
GB1541321A (en) 1979-02-28
IL51581A (en) 1980-02-29
PT66278B (fr) 1978-08-08
CS190341B2 (en) 1979-05-31
SU629882A3 (ru) 1978-10-25
FR2343748B1 (en:Method) 1980-07-18
PL102603B1 (pl) 1979-04-30
HU172685B (hu) 1978-11-28
FR2343748A1 (fr) 1977-10-07

Similar Documents

Publication Publication Date Title
FR2365572B1 (en:Method)
FR2343748B1 (en:Method)
FR2351335B1 (en:Method)
FR2352009B1 (en:Method)
JPS5615686B2 (en:Method)
JPS5350489U (en:Method)
JPS5743013Y2 (en:Method)
JPS5349887U (en:Method)
JPS5345036U (en:Method)
JPS5293266U (en:Method)
JPS567993Y2 (en:Method)
JPS5375211U (en:Method)
JPS5297657U (en:Method)
JPS5359741U (en:Method)
JPS5355874U (en:Method)
JPS52167614U (en:Method)
JPS5345516U (en:Method)
JPS52108391U (en:Method)
CH606749A5 (en:Method)
CH605000A5 (en:Method)
CH607278A5 (en:Method)
CH607366A5 (en:Method)
CH614070A5 (en:Method)
CH604981A5 (en:Method)
CH607433A5 (en:Method)